Ledger.Open graph →

SEC Form D · filed July 2, 2024

Cognito Therapeutics Ltd

Offering

$60.0M

Sold

$10.2M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Gerald Chan · Cambridge, MADirector Helen Liang · Cambridge, MADirector Richard Kuntz · Cambridge, MADirector Brent Vaughan · Cambridge, MAExec · Director Stephen Bruso · Cambridge, MADirector John Gutierrez · Brooklyn, NYExec · Director Richard Kuntz · Cambridge, MADirector Andrew Michau · Brooklyn, NYDirector Michael T. Lawless · Boulder, CODirector David Tugendhaft · Brooklyn, NYDirector Jeffrey Halis · Cambridge, MADirector Laura Brege · Cambridge, MADirector Chun Yi George Bridge Tower Partners GP, LP · Dallas, TXExec · Director Roger T. Johnson · Glendale, AZDirector Richard H. Lewis · Saskatoon, Saskatchewan, CanadaDirector Per Langoe · Tempe, AZDirector Ross Pearlman, Md · Madison, MSDirector Jeffrey Halis · Cambridge, MADirector Laura Brege · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗